Matt Peter Marinkovich
Stanford University
H-index: 63
North America-United States
Top articles of Matt Peter Marinkovich
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes | 2024/2/29 | ||
Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice | Journal of Investigative Dermatology | Ke Jing Tyler JM Jordan Ning Li Susan Burette Baoqi Yang | 2024/1/1 |
Reply to:“Comment on ‘Occurrence of vismodegib-induced cramps (muscular spasms) in the treatment of basal cell carcinoma: A prospective study in 30 patients'” | Journal of the American Academy of Dermatology | Matthew S Dinehart Stacy McMurray Scott Dinehart Mark Lebwohl | 2023/1/1 |
868 Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa | Journal of Investigative Dermatology | P Pathmarajah J So J Nazaroff N Harris MP Marinkovich | 2023/5/1 |
905 Long term use of topical beremagene geperpavec (B-VEC) in two patients with dystrophic epidermolysis bullosa | Journal of Investigative Dermatology | I Bagci N Momin B Agostini H Chen G Feeney | 2023/5/1 |
Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer | Nature Materials | Julie Chang Aashrith Saraswathibhatla Zhaoqiang Song Sushama Varma Colline Sanchez | 2023/11/13 |
178 Neutrophil elastase is critical in linear IgA bullous dermatosis in mice | Journal of Investigative Dermatology | N Li S Burette B Yang MP Marinkovich L Diaz | 2023/5/1 |
Treatment with ataluren for wound healing and health complications in a patient with junctional epidermolysis bullosa | JAMA dermatology | Gregory M Orlowski Shinya U Amano Kelly E Flanagan Kerri E Rieger M Peter Marinkovich | 2023/10/1 |
Mixed IgM-and IgA-mediated epidermolysis bullosa acquisita associated with IgM-λ paraproteinemia in an 81-year-old woman | JAAD Case Reports | Thinh Chau Joseph Wu Benjamin Kahn Christopher Elco M Peter Marinkovich | 2023/4/1 |
Mapping the burden of severe forms of epidermolysis bullosa–Implications for patient management | JAAD international | Jemima E Mellerio Dimitra Kiritsi M Peter Marinkovich Natividad Romero Haro Kellie Badger | 2023/6/1 |
Localized CO2 laser treatment of a recalcitrant oral ulceration in pemphigus vulgaris | Clinical Advances in Periodontics | Nita Chainani‐Wu Vinitha Gopal‐Murthy Aadi Wu M Peter Marinkovich | 2023/3 |
806 Results from VIITAL: A phase 3, randomized, intrapatient-controlled trial of an investigational collagen type VII gene–corrected autologous cell therapy, EB-101, for the … | Journal of Investigative Dermatology | JY Tang MP Marinkovich K Wiss D McCarthy A Truesdale | 2023/5/1 |
GEM-3: phase 3 safety and immunogenicity results of beremagene geperpavec (B-VEC), an investigational, topical gene therapy for dystrophic epidermolysis bullosa (DEB) | M Marinkovich M Gonzalez S Guide I Sinem Bagci Surya Chitra | 2022/8/1 | |
Collective invasion of the basement membrane in breast cancer driven by forces from cell volume expansion and local contractility | bioRxiv | Julie Chang Aashrith Saraswathibhatla Zhaoqiang Song Sushama Varma Colline Sanchez | 2022/7/31 |
Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa | New England Journal of Medicine | Shireen V Guide Mercedes E Gonzalez I Sinem Bağcı Brittani Agostini Hubert Chen | 2022/12/15 |
The Treatment of Wounds Associated with Recessive Dystrophic Epidermolysis Bullosa with Local Injections of Gene-Corrected, Collagen VII-Expressing Autologous Human Dermal … | M Peter Marinkovich Kunju J Sridhar I Sinem Bagci John AM Dolorito Douglas R Keene | 2022/4/1 | |
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa | Orphanet Journal of Rare Diseases | Jodi Y So Jaron Nazaroff Chinonso V Iwummadu Nicki Harris Emily S Gorell | 2022/10/17 |
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial | Nature medicine | Irina Gurevich Pooja Agarwal PeiPei Zhang John A Dolorito Stacie Oliver | 2022/4 |
LB952 A phase 1 trial of DSG3-CAART cells in mucosal-dominant pemphigus vulgaris (mPV) patients: Preliminary data | Journal of Investigative Dermatology | DJ Chang S Basu R Micheletti E Maverakis M Marinkovich | 2022/8/1 |
454 Genotype-phenotype associations in recessive dystrophic epidermolysis bullosa (RDEB) | Journal of Investigative Dermatology | J So N Harris S Fulchand E Gorell J Nazaroff | 2022/8/1 |
